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Abstract  	  
One of the most prevalent hypotheses pertaining to the sequence of events that lead to 
cystic fibrosis (CF) airway disease is that in normal airway epithelia the Cystic Fibrosis 
Transmembrane conductance Regulator (CFTR) anion channel inhibits the activity of the 
Epithelial Na+ Channel (ENaC). In CF patients, where CFTR is mutated, the inhibition of ENaC 
is lost. Consequently, ENaC becomes hyperactive, resulting in fluid depletion from the airway, 
collapse of the mucociliary apparatus, and impaired clearance of microbes, which initiates a 
cycle of infection and inflammation that may eventually result in respiratory failure. This 
hypothesis has recently been challenged by reports suggesting that animal models of CF do not 
exhibit hyperactive ENaC, and that the cilia in their airway appear normally functioning. This 
constitutes a paradigm shift in CF with serious consequences for current and future CF 
treatments. However, there is evidence that ENaC hyperactivity in CF may depend on the 
stimulation of airway epithelia by secretagogues. Thus, using a self-referencing ion selective 
microelectrode technique with unparalleled spatial resolution, we tested the Na+ transport 
properties of the surface epithelia in the distal airway (~2mm) of CFTR-\- swine after stimulation 
of intracellular cAMP or Ca2+ signaling pathways. We show that the epithelial cells located at the 
folds of the distal airway are capable of both secreting and reabsorbing Na+, and are sensitive to 
CFTR and ENaC inhibition with CFTRinh172 and amiloride, suggesting that both ENaC and 
CFTR are expressed at the folds. Most importantly, using the response to amiloride as an assay 
for ENaC activity, we detected hyperactive ENaC in forskolin-stimulated CFTR-/- airways. This 
indicates that CFTR-/- swine airways do indeed suffer from hyperactive ENaC after increased 
intracellular cAMP, thus potentially collapsing the PCL at those sites. 
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1. Introduction: 
1.1. CF overview  
Cystic fibrosis (CF) is one of the most common lethal hereditary diseases among 
Caucasian populations. In North America, carrier prevalence of the impaired genes is 1:30 while 
the actual disorder occurs 1 in approximately 3500 live births (Dupuis et al., 2005). Worldwide, 
approximately 70,000 patients with CF were registered by World Health Organization (World 
Health Organization, 2002; World Health Organization, 2004). Most CF cases occur in 
populations of Caucasian descent (Europe, North America, and Australia); however, it does 
occur in other populations (Cystic Fibrosis Foundation, 2015). According the Canadian CF 
registry (2014), there are over 4000 CF patients diagnosed in Canada. The current estimated 
median survival age for Canadians is 58.1 years with a tendency of increasing every year 
(Canadian CF registry 2018).  
Cystic Fibrosis is an autosomal recessive genetic condition caused by mutations (over 
2000 mutations) in the gene encoding for the anion channel, Cystic Fibrosis Transmembrane 
conductance Regulator (CFTR) (Griesenbach, 1999; Boucher, 2003). All epithelial cells that 
normally express CFTR are dysfunctional in CF patients, resulting in abnormalities in many 
organs including pancreas, liver, intestine and reproductive organs. However, most of the 
morbidity and mortality in cystic fibrosis patients arises from CF airway disease (Morton & 
Glanville 2009; Leitch, & Rodgers, 2013). Cystic fibrosis patients are born with apparently 
normal lungs. However, in the first few years of life they acquire chronic and unrelenting 
bacterial infections of the airways (Rajan & Saiman, 2002; Chmiel & Davis, 2003). Patients 
suffer from transient bronchitis-like airway infections, frequently with the bacterium 
Pseudomonas aeruginosa. Genetic fingerprinting studies show that these first infections are 
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distinct events; infection develops and is subsequently cleared, and the next bout is caused by a 
new strain acquired from the environment (Burns et al., 2001). Unfortunately, this stage is 
temporary, as the airways of nearly all patients eventually become permanently colonized by 
mucoid P. aeruginosa (Nguyen & Singh, 2006), which is a variant phenotype that produces an 
exopolysaccharide alginate and causes mucoidy, conferring resistance to phagocytosis (Pier et 
al., 2001) and antibiotics (Hodges & Gordon, 1991). Mucoid P. aeruginosa forms a biofilm that 
cannot be cleared and eradicated (Koch, 2002), and its presence predicts shortened CF patient 
survival (Henry et al., 1992, Li et al., 2005). 
1.2. CFTR 
1.2.1. CFTR ,ENaC structures and functions 
The CFTR gene consists of nearly 190 kb of genomic DNA found in the long arm of 
chromosome 7 (7q21-34) (Ellsworth et al., 2000). The product of CFTR gene expression is 
known to be a multifunctional protein, member of the ATP-binding cassette transporter 
superfamily that also includes multidrug resistance proteins. These proteins may act as 
transporters as well as perform regulatory functions modulating transepithelial conductance 
(Schuetz et al., 1999; Rees et al., 2009, Riordan et al., 1989). A large body of research indicates 
that in addition to its channel function, CFTR modulates Na+ reabsorption (Egan et al., 1992; 
Gabriel et al., 1993; Alton et al., 1993). 
CFTR consists of two membrane-spanning domains (MSD1 and 2) followed by 2 
nucleotide-binding domains, NBD1-2 (Riordan et al., 1989), and a regulatory domain (R-
domain). The R-domain is responsible for gating the channel and it is phosphorylated by protein 
kinase A (PKA) and protein kinase C (PKC) (Liedtke et al., 2002; Guggino & Stanton, 2006; 
Auerbach & Liedtke, 2007). The MSDs consists of six membrane-spanning peptides that form 
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the pore of the channel, connected by hydrophilic loops crucial for maintaining stability of CFTR 
(Manavalan et al., 1994). Furthermore, specific amino acids encoded in the membrane-spanning 
domains determine the selectivity of CFTR to Cl- and other anions (e.g. HCO3-, Sheppard & 
Welsh, 1999). The NBDs regulate binding and hydrolysis of ATP, providing the channel with 
the energy needed for opening and closing the pore (Anderson et al., 1991; Gadsby et al., 1999). 
Several studies have shown that CFTR R-domain comprises multiple protein kinase-A 
phosphorylation sites that are important for gating activation (Chappe et al., 2005; Hwang et al., 
2013). Phosphorylated R-domain initiates binding and hydrolysis of ATP by NBDs leading to 
changing of pore conformation (open state) (Sheppard, & Welsh, 1999). 
All conductive airway epithelia are able to reabsorb sodium through the amiloride-
sensitive apical ENaC (Mall et al., 1998; Kunzelmann et al., 2002; Scott et al., 1987; Bange et 
al., 2008). ENaC consists of three homologous α-, β-, and γ-subunits (Canessa et al. 1994). 
Proper function of the ENac channel requires polymerization of all three subunits in the cell 
membrane (Staruschenko et al., 2005; Stockand et al., 2008). Subunits include two intracellular 
segments with NH2- and COOH- terminals separated with two transmembrane (TM, TM2) 
sequences and one extracellular domain (Canessa et al., 1993). Regulation of ENaC activity 
depends on structure and composition of intracellular terminals of βγ-subunits. Some studies 
showed elevated ENaC activity together with increased expression of the channel due to 
mutations of C- and N-termini of the βγ-subunits (Firsov et al., 1996; Tamura et al., 1996). As in 
many other channels, modulation of ENaC activity could be facilitated by changing two main 
parameters: quantity of expression and open probability (Garty & Palmer 1997; Rossier 2002). 
  
1.2.2. CFTR mutations. 
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In 1946, Anderson and Hodges first found evidence that supported the genetic nature of 
cystic fibrosis (Anderson & Hodges, 1946). They estimated an approximately 25% rate of 
occurrence of CF in afflicted families, which is explained by the recessive type of CF 
inheritance. Further investigation on CF patient abnormalities revealed an electrolyte imbalance 
of Cl- in sweat secretion that enlightened the etiology of CF (Majka et al., 2003). Since the CFTR 
gene was identified in 1989 (Kerem et al., 1989; Riordan et al., 1989), the biological basis of the 
ion transport abnormalities became clearer. Over the last three decades more than 2000 CF 
causing mutations of CFTR were discovered (Castellani et al., 2008; 
http://www.genet.sickkids.on.ca/StatisticsPage.html). CFTR mutations are grouped in six classes 
depending on the type of dysfunction they cause. Class I includes mutations encoding nonsense 
mRNA, which cannot be translated. Class II mutations cause protein misfolding that precludes 
CFTR trafficking to the membrane. Thus, expression of CFTR channels in the cell membrane is 
minimized. The most common mutations found in 70% of CF patients are class II mutations. A 
deletion of a phenylalanine in position 508 of MSD1 (Phe508del) is one of the common second 
class mutation that leads to misfolding of the channel (Bobadilla et al., 2002). Class III mutation 
is a “gating” type of mutations that leads to the production of dysfunctional proteins. CFTR 
proteins are synthesized and trafficked to the cell membrane, but the opening of the channel is 
disrupted due to inability to bind and to hydrolyze ATP (Logan et al., 1994; Bompadre et al., 
2007). Common Class III mutations are G551D and G1349D mutations in NBD1 and NBD2 
respectively,  that diminish the ability to bind and hydrolyze ATP , thus reducing gating by 10 to 
100 times (Bompadre et al., 2007). G551D is the third most common mutation that causes severe 
CF symptoms (http://www.genet.sickkids.on.ca/cftr/app). Class IV mutations are those that result 
in reduced anion conductivity. These are associated with a moderate form of CF lung disease that 
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usually manifest in early age (O’Sullivan et al., 2006). One of the most frequent mutations of the 
class is R117H, where an arginine is substituted with histidine at position 117 of CFTR. Some of 
the mutated proteins are incapable of folding and undergo degradation upon synthesis. Those 
CFTRs that are properly folded form channels with by approximately 25% reduced in ion 
conductance, as well as lower open probability (Yu et al., 2016). In class V mutation, altered 
stability of mRNA produces damaged proteins and the expression of normally functioning 
CFTRs is reduced; thus, overall ion conductance is reduced compared to healthy epithelium, 
causing non-symptomatic or mild clinical phenotype (De Boeck et al., 2014). For instance, the 
splicing mutation 2789 + 5 G-A (frameshift splice) producing only 4% of correctly spliced 
CFTR, while the rest results in a truncated CFTR (Highsmith et al., 1997). Class VI mutations 
generate unstable proteins or proteins with impaired anchoring segment and increase turnover of 
the protein (Wang et al., 2014; Pettit & Fellner, 2014). The C-terminal truncation of CFTR due 
to premature activation of a stop codon or frameshift results in significant pancreatic deficiency 
and mild lung disease (http://www.genet.sickkids.on.ca/cftr/).   
CFTR mutations affect the function of epithelial tissues, which normally express CFTR, 
altering the function of many organ systems, such as the respiratory system and the 
gastrointestinal tract. Currently, most of the mortality and morbidity faced by CF patients results 
from lung disease. 
 
 
1.3. CFTR and epithelial tissues. 
1.3.1. Epithelial tissue structure and function. 
Of all the tissue types found in the animal body, the epithelial tissue (from the Greek epi-
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over and thele-peels) is the most ancient, which in the phylo- and ontogenesis arise first (Kenney 
et al., 2015). The epithelium is a layer of epithelial cells attached by tight joints to form a sheet 
of tissue (Fox, 2006). Thus, separating the external from internal environment, as well as lining 
all internal organs, and forming glandular organs in animals (Kenney et al., 2015). 
Epithelia separate the body from the environment and perform important functions to 
protect the underlying tissues from various external insults, such as chemical, mechanical, and 
infectious challenges (Griesenbach, 1999; Boucher, 2003). Epithelial tissues also mediate the 
exchange of solutes and water with the environment by carrying out reabsorption and secretion 
of substances (Sherwood, 2015). For example, through the intestinal epithelium, products of food 
digestion are absorbed into the blood and lymph. In addition, the epithelium covering the internal 
organs creates compartments with conditions required to support specialized cells (e.g. neurons) 
to perform their function. Finally, glandular epithelia have a secretory function, synthesizing and 
secreting diverse substances required for different processes. For example, secretions from the 
pancreas facilitate digestion of proteins, fats and carbohydrates in the small intestine, or airway 
submucosal glands that are involved in innate immune defense (Stanfield, 2012). 
1.3.2. Epithelia in the airway and cystic fibrosis disease. 
Epithelial lining is present in the entire bronchial tree starting from the trachea and 
continuing through the airways toward terminal bronchioles and alveoli (Ayers & Jeffery, 1982). 
Large bronchi are lined with ciliated pseudostratified columnar epithelium that varies in 
thickness depending on bronchial division and is gradually decreasing in height. In terminal 
bronchioles the epithelium becomes flatter, turning in cuboidal form (Jeffery, 1983; Jeffery, 
1995). Ciliated epithelial cells are the major component of the respiratory epithelium and are 
found through all conductive airways. The synchronised motion of the cilia drives the movement 
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of the mucus layer, and pathogens trapped within it, towards the pharynx and out of the airways. 
This process, termed mucociliary clearance (MCC), and is central for airway innate defense, and 
provides the mechanical removal of pathogens and inhaled particles from lungs. In cystic 
fibrosis, mucociliary clearance fails, thus facilitating infection and inflammation that may 
eventually lead to respiratory failure (Griesenbach, 1999; Boucher, 2003). 
1.4. Mucociliary clearance. 
 Mucociliary clearance is a complex mechanism of lung innate defense mechanism that 
helps eradicate microorganisms and foreign particles from the airways (Robinson et al., 2000; 
Knowles & Boucher, 2002; Sagel et al., 2011). Airway epithelial cells in the respiratory tract 
contribute to the production of mucus, and the cilia create a mechanical force for MCC (Wanner 
et al., 1996).  
Mucus is a gel-like secretion, overlaying the ciliated epithelia (Thornton & Sheehan, 
2004; Cone, 2009). Mucus gel consists of the 97% water and 3% solids, including mucins and 
antibacterial peptides. Mucins are large glycoproteins (~3×106 D) that consist of one or several 
protein monomers with abundant regions of serine and threonine residues bound to sugar 
monomer O-glycan (Thornton & Sheehan, 2004). Approximately 30% of all solids in mucus are 
mucins (Thornton et al., 2008).  The human genome contains 17 genes encoding mucins, among 
them 10 are membrane-bound and the rest are secreted (Hattrup & Gendler, 2008).  Some 
mucins have terminal cysteine-rich domains allowing them to polymerize due to disulfide bonds. 
Such polymerization forms the mesh of mucins that contribute to the gel-like properties of mucus 
(Thornton & Sheehan, 2004). In addition to mucins, respiratory mucus contains antimicrobial 
peptides, such as siderocalin, which binds to bacterial siderophores depriving the microorganism 
from iron as well as modulating pulmonary macrophages, converting them to anti-inflammatory 
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phenotype from pro-inflammatory one (Warszawska et al., 2013). Other antimicrobial 
compounds include lactoferrin, lysozyme (Bowes et al., 1981; Hinnrasky et al. 1990), 
lactoperoxidase, which facilitates production of the antimicrobial hypothiocyanite (Gerson et al., 
2000; Wijkstrom-Frei et al., 2003), cathelicidin, and β-defensins that kill bacteria by destroying 
bacterial membranes (Bals et al., 1998).  
The second component of MCC, in addition to mucus, is cilia movement, since ciliary 
beating drives mucociliary clearance (Knowles & Boucher, 2002). The velocity of mucociliary 
clearance depends, among other factors, on the ability of the cilia to move efficiently. In CF 
lungs cilia movement seems to be compromised due to the dehydration of airway surface liquid, 
reducing the volume of airway surface liquid around the cilia, thus resulting in the collapse of the 
cilia, abrogating ciliary movement (Tarran et al., 2006; Rubin, 2007).    
  
1.4.1. Airway surface liquid 
The layer of mucus discussed above is not in direct contact with the surface epithelia. 
Instead, there is a layer of fluid between the mucus layer and the epithelial cells termed the 
periciliary liquid (PCL) layer. Together, the mucus layer and the PCL form the Airway Surface 
Liquid (ASL).  
The PCL layer is regulated at approximately 7 um in height, ideal to facilitate cilia 
movement that drives mucociliary clearance of inhaled particles, including pathogens. In distal 
airways, the PCL is regulated by airway surface epithelial cells though the active secretion and 
reabsorption of ions and water (Widdicombe, 2002).  
The regulation of PCL volume is mediated by two competing activities: Na+-driven fluid 
reabsorption versus Cl--driven fluid secretion into the lumen of the airway. Reabsorption of PCL 
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involves activation of apical epithelial Na+ channels (ENaC) and basolateral N+/K+- ATPase. In 
contrast, PCL secretion requires activation of CFTR on the apical membrane and Na+/K+/2CL- 
cotransporters facilitates Cl- uptake on basolateral membrane, providing transcellular transport of 
chloride ions (Frizzell et al., 1981). The failure to regulate of PCL volume in CF has long been 
considered the pathogenic event in lung disease.  
 
1.5. Pathogenesis of CF  
For more than 20 years the consensus in the CF field was that in normal airways CFTR 
inhibits ENaC function and that this inhibition is lost in CF airways (Boucher et al., 1986, Briel 
et, al., 1998), resulting in hyperactivity of ENaC, which depletes the PCL, collapsing the cilia, 
and eventually abrogating mucociliary clearance in the airway (Hobbs et al., 2013). This inability 
to clear bacteria would initiate a pathological cascade in CF lungs, promoting infection, 
inflammation, and airway remodeling (Boucher, 2007).  
This long-standing and widely accepted hypothesis has recently been challenged by 
studies utilizing new CF animal model systems. Welsh and coworkers reported that the upper 
airways of CFTR-\- pigs do not display hyperactive ENaC or increased Na+ reabsorption from 
the PCL, the cilia and PCL appear normal (Chen et al 2010), and the basal mucociliary clearance 
is normal (Hoegger, 2014). Other studies in CFTR-/- ferrets (Sun et al., 2010, Fisher et al., 2013) 
and rats (Tuggle at al., 2014) as well as in human CF cell cultures (Itani et al., 2011) found no 
evidence of hyperactive ENaC. Moreover, Quinton and co-workers suggested that ENaC and 
CFTR are not expressed by the same cells of the airway surface epithelia (Shamsuddin, & 
Quinton, 2012; Flores-Delgado et al., 2016), contradicting previous results (Grubb et al., 2012). 
Instead, they propose that cells located in the pleats of the distal airway epithelia express CFTR 
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and specialize in secreting fluid (Fig. 1A), while cells on the folds express ENaC and specialize 
in reabsorption (Shamsuddin & Quinton, 2012; Flores-Delgado et al., 2016), thus, ENaC-CFTR 
interaction is not possible.  
 
 
 
1.6 Rationale  
These reports constitute a paradigm shift in our understanding of CF airway disease 
pathogenesis and challenge the very basis of some current CF treatments, such as nebulization 
with hypertonic saline, and the development of new ones based on ENaC activity modulation 
(Goralski et al., 2010). However, the contribution of hyperactive ENaC to CF pathogenesis has 
not been fully tested since the phenotype displayed by CF airway epithelia may depend on the 
stimulation of the epithelia cells by secretagogues. For example, CFTR-/- swine airway display 
abnormal mucociliary clearance only after cholinergic stimulation of the airway (Hoegger et al., 
2014), and stimulation of intracellular cAMP increases ENaC hyperactivity in CF airway 
epithelial cells (Boucher et al., 1986; Stutts et al., 1995; Chambers et al., 2005). The activity of 
ENaC in CFTR-/- swine after stimulation of epithelial cells treated with secretagogues has never 
been tested. 
 
1.7 Objectives 
Therefore, we investigated ion transport properties of the distal airways (~2 mm 
diameter) in wild-type and CFTR-\- swine after stimulating intracellular cAMP or Ca2+ signaling 
with forskolin or thapsigargin, respectively. We used a high resolution self-referencing ion-
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selective microelectrode technique that allows us to measure Na+ transport properties at the folds 
of the distal airway.   
 
1.8 Hypotheses: 
We propose two main hypotheses: 
1) Airway surface epithelial cells can both secrete and reabsorb fluid and ions (Fig. 1-1) 
2) In CF airways, Na+ transport is hyperactive  
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Figure 1-1: Schematic illustration of two alternative theories of ASL regulation in 
distal airways. 1) The distal airway consists of two cell populations with different transport 
properties. The epithelial cells in the pleats secrete liquid, Na+ and Cl- in to the lumen via CFTR-
mediated transport. The folds reabsorb fluid, Na+ and Cl- though an ENaC process. 2) A small 
airway epithelium is a homogeneous cell population. Cells in fold and pleat regions are capable 
of bidirectional sodium transport. 	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2. Methods 
2.1. Animals. 
We used lungs from 2-7 days old gut-corrected CFTR knockout pigs (CFTR–/–
;TgFABP>pCFTR pigs) purchased from Exemplar Genetics (Exemplar Genetics, Sioux Center, 
IA). Lungs from male and female ~7 days old wild-type pigs were used as controls (Prairie 
Swine Centre, University of Saskatchewan). The CFTR-/- and wild-type lungs were dissected 
within 15-30 min of euthanasia, clamped to prevent fluid penetration into the lumen, and placed 
in ice-cold Krebs-Ringer solution (mmol/l: 115 NaCl, 2.4 K2HPO4, 0.4 KH2PO4, 1.2 CaCl2, 1.2 
MgCl2, 25 NaHCO3, 10 glucose at pH = 7.4) containing 1 µM indomethacin to minimize tissue 
exposure to endogenously generated prostaglandins and equilibrated with 95% O2-5% CO2. We 
used the tissue for experimentation within 12 h of euthanasia since preliminary data show no 
significant decay in the viability of the tissue within that time (see Appendix I). All procedures 
were approved by the Animal Care Committee of the University of Saskatchewan. 
2.1.1. Tissue preparation 
Blocks of tissue (3 cm3) were excised from the lower lobes of the lungs. Using a 
dissecting microscope we identified and dissected small airways (~2 mm in diameter and ~5 mm 
in length). The airway preparation was cut longitudinally to expose the lumen and producing a 
block of tissue of ~6 by 5 mm, and ~1 mm height. Prior to and during ion flux measurements the 
airway tissues were maintained at 37 ± 2°C using a custom-built temperature control system. We 
tested the ion transport properties of the folds (i.e. regions that extend into the lumen of the 
airway) since it provides easier access for the electrodes. 
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2.2. Scanning Ion-selective Electrode Technique (SIET). 
Epithelial solute transport generates a concentration gradient of the transported solute 
adjacent to the cell membrane, i.e. unstirred layer (Fig. 2-1A). The intensity of the unstirred layer 
is proportional to the epithelial transport rate (Barry and Diamon 1984).  Hence it is possible to 
map and measure patterns of solute flow, in our case Na+, across an epithelial surface by 
measuring the ion concentration gradients in the unstirred layer and using Fick’s law of diffusion 
to calculate the diffusion rate, which in steady state matches epithelial Na+ flux (Kfihtreiber and 
Jaffe, 1990).  
We used SIET (Fig 2-1 A and B, Applicable Electronics, Forestdale, MA, USA), a self-
referencing non-invasive method, to measure transepithelial Na+ flux with great spatial and 
temporal resolutions (Smith et al., 1994, Piñeros et al., 1998, Somiesk and Nagel 2001). Na+ flux 
measurement is a surrogate for NaCl (or NaHCO3-) transport across the epithelia since Na+ 
transport rate must be matched by a counterion (e.g. Cl- or HCO3-) to maintain electroneutrality.  
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Figure 2-1: SIET experimental setup. A) Schematic diagram of the Na+ gradient 
(background colour intensity) generated by an epithelium that is transporting Na+ from the apical 
to basolateral side (red arrow) which generates an unstirred layer. SIET uses Na+-selective 
microelectrode to measure the Na+ concentration gradient and calculate the Na+ flux across the 
epithelia. B) Schematic representation of the SIET device. A video camera connected to a 
microscope facilitates placement of the electrode in the desired location. Movement of the 
electrode is computer-controlled. Measurements are collected and processed by the computer. C) 
Sample image of small airway. Preparations are placed luminal (i.e. apical) surface up in a 
temperature-controlled chamber and bathed in Krebs-Ringer solution. The tip of the Na+ 
microelectrode (*) is placed on the folds (black arrow) of epithelium which appear as light-grey 
to white ridges as opposed to the pleats (white arrow).  
C 
B 
* 
100	  µm 
A 
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SIET Na+ flux measurements are accomplished by conducting a series of computer-
controlled movements of a Na+-selective microelectrode to measure Na+ concentration at two 
points within the unstirred layer, which preliminary experiments determined needed to be 
separated by 50µm (Fig. 2-1 A and C). Ion selective microelectrode voltage was recorded for a 
sampling period of 0.5s. Then, the ion selective microelectrode was moved 50 µm away, 
followed by a 4s wait period, to ensure the re-establishment of the ion unstirred layer that may 
have been disturbed by the microelectrode movement, before another 0.5s sampling period 
(O'Donnell & Ruiz-Sanchez 2015). A whole measurement cycle was completed in ∼9.5 s. 
Reference measurements were collected at locations at least 0.5 mm away from the specimen, 
where no unstirred layer is detectable. All measurements made on the specimen were referred to 
the reference readings taken periodically during the experiment.  
 The Na+-selective microelectrode voltage gradient was converted to concentration 
gradient using: ∆𝐶 = Cb×10(∆! !) − Cb 
where ∆𝐶 corresponds to Na+ concentration gradient (µmol cm-3); Cb is background Na+ 
ion concentration (µmol cm-3); ∆V is the voltage gradient (mV), and S represents the 
microelectrode slope (mV) (Donini and O’Donnell, 2005).  
Using the Fick’s law of diffusion we converted the concentration gradients into ion fluxes 
(Smith et al., 1994): 𝐽 = 𝐷∆𝐶 ∕ ∆𝑋 
where J is Na+ ion flux across the epithelial cells measured in pmol cm-2 s-1; D is 
diffusion coefficient for the sodium ion (1.55×10-5 cm2 s-1); ∆𝐶 is concentration gradient, ∆𝑋 is 
the distance in cm between the two measuring points.  
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2.2.1. Na+–selective microelectrodes construction 
Na+–selective microelectrodes were constructed from borosilicate capillaries (TW150-4; 
WPI, Sarasota, FL, USA). Electrodes were pulled using a Narishige PC-100 puller, and salinized 
with dichlorodimethylsilane at 250°C for at least 6 hours (Doninni and O’Donnell, 2005). The 
tip of each electrode was filled with a 50 µm column of Na+ Ionophore II Cocktail A (Fluka) and 
backfilled with 100 mmol l-1 NaCl solution. The microelectrodes were calibrated in 150 mmol l-1 
NaCl and 15 mmol l-1 NaCl + 135 LiCl solutions. Electrodes that display a voltage change 
smaller than 50 mV per 10 times change in Na+ concentration in the calibration solutions (i.e. 
slope of the electrode) were excluded from the experiment. Our electrodes had an average slope 
of 55±5 mV (n=78). The reference electrodes were 4% agar bridges in 500 mmol l-1 KCl. 
 
2.3. Reagents 
CFTRinh-172 was obtained from Cedarlane Labs (Burlington, ON, CA). Forskolin and 
thapsigargin were purchased from Sigma-Aldrich. Stock solutions of CFTRinh-172, forskolin, 
and thapsigargin were dissolved in DMSO. The final concentration of DMSO was less than 
0.1%.  
 
2.4. Statistics  
Data are presented as mean ± S.E.M. The data sets that met the assumption of normality 
and homogeneity of variances where analyzed with parametric tests, ANOVA or Student’s t test. 
For those that did not, we performed non-parametric tests using GraphPad Prism 5 (GraphPad 
Software Inc., San Diego, CA, US), and p < 0.05 was considered significant. Preliminary 
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experiments showed that a sample size of 6 samples was sufficient to ensure adequate power to 
detect the effects of treatment on PCL secretion. We did not exclude any data from our analysis. 
3 Results  
3.1 SIET measurements in distal airway epithelium  
3.1.1 SIET electrode efficiency 
 To determine the how well our SIET set up and sampling protocols measured ion flux 
we tested the efficiency of SIET Na+ flux measurement (Piñeros et al., 1998).  We produced an 
artificial Na+ source by filling a micropipette (tip diameter ~10µm) with 1M NaCl plus 0.5% 
(w/v) agar to minimize bulk water flow. The source was placed 50µm away the bottom of the 
experimental chamber filled with Krebs-Ringer solution containing 140 mM Na+ (Piñeros et al., 
1998; Donini, & O'Donnell, 2005). 
Theoretical values for the Na+ gradient generated by the source pipette were calculated 
according to Piñeros et al., 1998 (Fig. 3-1 A). 
ΔV=S[(-U Δr)/(CB r2 + U r)]/ 2.3 
where ΔV is the change (mV) over the electrode excursion, S is the slope of the electrode, 
r is the distance from the source, Δr is the amplitude of vibration, CB is the background 
concentration of Na+ and U is an empirical constant. To calculate U we measure Na+ electrode 
voltage at known distances from the Na+ source and calculated Na+ concentrations values using 
the calibration curve and plotted them vs the inverse of the distance from the Na+ source (1/r) 
adjusted the data to the equation (Fig. 3-1 B, Piñeros et al., 1998): 
C = CB + U/r 
To determine the efficiency of our SIET Na+ microelectrode we compared the theoretical 
value to the actual Na+ flux measured using the SIET with the Na+ microelectrodes and protocols 
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used in our experiments (Fig 3-1 A). The efficiency of SIET measurements is calculated as the 
ratio of the slope of the experimental data to the slope of the theoretical data (Fig. 3-1 A, Piñeros 
et al., 1998). The efficiency of our SIET Na+ flux measurement was 75%, which is consistent 
with previous reports (Fig. 3-1 A, Rheault and O'Donnell, 2001).
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Figure 3-1: Electrode efficiency. A) Na+ microelectrode voltage difference as a function of 
distance from a Na+ source. Experimental measurements (circles) were made by vibrating the 
microelectrode through an amplitude of 100µm at each distance while the theoretical values 
(squares) where calculated. B) To calculate the empirical constant U, static measurements were 
made at a series of distances from the source, and the millivolt outputs were then converted to 
activity values and plotted versus the inverse of the distance from the Na+ source. Using the 
method of Piñeros et al. 1998, electrode efficiency (75%) was calculated as the ratio of the slope 
of the experimental data to the slope of the theoretical data. 
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3.1.2 SIET spatial resolution 
We estimated the spatial resolution of our SIET experimental protocol by measuring the 
ability of SIET to resolve two Na+ point sources (Fig. 3-2 A, Somiesk and Nagel 2001). The 
point sources consisted of two borosilicate micropipettes filled with 1M NaCl in 0.5% agarose, 
with ~5µm tip diameter and separated by 35 µm.  Using SIET we measure the Na+ flux at each 
point source and the space separating the sources every 5 µm (Fig. 3-2 B). The data shows that 
SIET can easily resolve these two point sources, suggesting that the space resolution of the 
technique allow us to resolve fold from pleat, which in our preparation are separate by ~50µm. In 
addition, we determine whether the Na+ gradient measured at the folds was influenced by the ion 
transport across the pleat. We measured the forskolin-stimulated Na+ flux at the fold and on the 
same plane but over the pleats, located ~50 µm away (Fig. 3-3 A). The results show that over the 
pleats, forskolin produced a very small Na+ gradient, which is only ~0.02 % of the flux measured 
on the folds (Fig. 3-3 B and C). These measurements indicate that any contribution of the pleat to 
our Na+ flux measurements on the fold is insignificant. 
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Figure 3-2: SIET spatial resolution. We estimated the spatial resolution of our SIET 
experimental protocol by measuring the ability to resolve two Na+ point sources. A) Image of an 
experimental set up depicting the two borosilicate micropipettes filled with 1M NaCl in 0.5% 
agarose, with ~5µm tip diameter and separated by 35 µm.  Using the Na+ selective 
microelectrode (ISME), the Na+ flux was measured at each point source and the space separating 
the sources every 5 µm. B) The data shows that SIET can easily resolve these two point sources, 
suggesting that the space resolution of the technique allow us to resolve fold from pleat in our 
preparation.  
23	  
Figure 3-3: Contribution of pleat Na+ transport to fold measurements. A) In order to 
determine whether the Na+ gradient generated by the pleat contributes to our measurements at 
the folds, we measured forskolin-stimulated Na+ flux at the fold and on the same plane but ~50 
µm to the side, where the pleats are located. B and C) The results show that the Na+ flux was 3.9 
nmol cm-2 s-1 at the folds and 0.001 nmol cm-2 s-1 over the pleats which only ~0.02% of the 
forskolin signal measured at the folds. Asterisk denotes statistical significant difference. 
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3.2 Evaluation of the ion transport properties of the distal airway surface 
epithelium 
Welsh and coworkers used the response to amiloride, an ENaC blocker, as an assay for 
ENaC activity in the upper airway of CFTR-/- swine (Chen et al., 2010) and CF human epithelial 
cell cultures (Itani et al 2011). We followed a similar approach to test for ENaC activity in the 
distal airway of wild-type and CFTR-\- swine. We measured Na+ flux across the folds, i.e. the 
segments of tissue protruding into the lumen of the airway, of the distal airway epithelia (~2 mm 
diameter) using Scanning Ion-selective Electrode Technique (SIET) that is capable of spatial 
resolution unparalleled by previous studies in CF.  We detected a basal level of Na+ flux in both 
wild-type and CFTR-/- swine with a significantly different frequency distribution (Fig. 3-4). 
These results show that the folds are capable of both secreting and reabsorbing fluid, 
contradicting the hypothesis that the folds of the tissue are specialized for reabsorption 
(Shamsuddin, & Quinton, 2012; Flores-Delgado et al., 2016). 
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Figure 3-4: Frequency distribution of basal Na+ flux in wild-type and CFTR-/- distal 
airway. The frequency distribution of wild-type and CFTR-/- swine is statistically different, with 
the data more tightly grouped around 0 values for CFTR-/- animals (p < 0.05 Chi-square test). 
The mean Na+ flux of -0.3 ± 0.1 in wild-type, and 0.05 ± 0.03 nmol cm-2 s-1 in CFTR-\- (p < 0.05 
Unpaired t test with Welch's correction, wild-type n = 216 from 12 pigs, CFTR-/- n = 269 from 
10 pigs).   
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Since cAMP has been shown to upregulate ENaC activity and increase Na+ reabsorption 
in CF but not in wild-type airway cell cultures (Boucher et al., 1986; Stutts et al., 1995, 
Chambers et al 2007), we tested the effect of amiloride on preparations pre-stimulated with 
forskolin, an adenylate cyclase activator, to increase intracellular cAMP. Our results show that 
stimulation of wild-type preparations with forskolin (1µM) triggered a transient increase in Na+ 
secretion into the lumen of the airway that peaked 4 ± 1 min after stimulation at 5 ± 2 nmol cm-2 
s-1, followed by a decrease in Na+ reabsorption to an average of 0.01 ± 0.7 nmol cm-2 s-1 (Fig. 3-5 
A, n = 15 sites from 8 pigs). Some sites responded to forskolin by triggering Na+ secretion 
initially and later reabsorption, demonstrating that a single site in the folds is able to both secrete 
and reabsorb fluid, rejecting Quinton and coworkers’ hypothesis (Fig. 3-5 A insert, Shamsuddin 
and Quinton, 2012; Flores-Delgado et al., 2016). The effect of forskolin was blocked by treating 
wild-type preparations with the CFTR blocker, CFTRinh172, (100 µM, Fig 7B, n = 21 sites from 
9 pigs). In CFTR-/- swine, forskolin did not significantly increase Na+ secretion (Fig. 3-5 C and 
D, n = 13 sites from 10 pigs, p<0.05 Kruskal-Wallis test, Dunn’s multiple comparison). These 
results are consistent with reports in human (Itani et al., 2011; Joo et al., 2002), CFTR-/- swine 
(Chen et al., 2010), rat (Tuggle et al., 2014), and mice preparations (Grubb et al., 1994; Boucher 
2007) suggesting that cAMP-stimulated fluid transport requires CFTR and is missing in CF 
airways. 
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Figure 3-5: Effects of foskolin on WT and CFTR-/- small airway epithelia. Positive 
values indicate Na+ flux from the basolateral side into the lumen of the airway, and negative 
values indicate transport in the opposite direction. A) Wild-type response to forskolin stimulation 
(1µM). Insert represent a sample trace showing Na+ secretion and reabsorption by the same site. 
B) Wild-type preparations incubated with the CFTR blocker, CFTRinh172 (100 µM) and C) 
CFTR-/- airway. D) Peak response to forskolin for wild-type swine was significantly larger than 
the response of preparation incubated with the CFTR inhibitor, CFTRinh172, and that displayed 
by CFTR-/- swine airway, columns labeled with different letters are statistically significance. 
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Pre-incubating preparations with forskolin and then treating them with amiloride 
produced an increase in Na+ secretion into the PCL, consistent with blockage of ENaC. The 
effect of amiloride was significantly larger in CFTR-/- than in wild-type swine (Fig 3-6A, 
CFTR-/- n = 12 sites from 8 pigs, wild-type n = 11 sites from 8 pigs, p > 0.05 repeated measures 
ANOVA). This suggests that cAMP stimulation may cause hyperactive ENaC in CF.  
Forskolin treatment may downregulate ENaC activity in wild-type pigs (Knowles et al., 
1983, 1990; Boucher et al., 1986), which may explain the difference observed in the amiloride 
response. We therefore compared the amiloride response of CFTR-/- preparations pre-incubated 
with forskolin (CFTR-/- + forskolin) to the amiloride response of wild-type swine that were 
never exposed to forskolin (Fig. 3-6B). The results show a significant difference between the 
response to amiloride by CFTR-/- and wild-type swine (Fig. 3-6 B, p < 0.05 repeated measure 
ANOVA, CFTR-/- n = 12 sites from 8 pigs, wild-type n = 18 from 7 pigs). Amiloride treatment 
triggered a peak response in Na+ flux into the ASL of 15 ± 5 nmol cm-2 s-1 in CFTR-/- 
preparations incubated with forskolin, and 4 ± 1 nmol cm-2 s-1 in wild-type preparations (Fig. 3-6 
B). This indicates that forskolin-treated CFTR-/- swine airway display ~4 times more ENaC 
activity than that of untreated wild-type preparation, consistent with the hypothesis that ENaC 
may be hyperactive in CF. The response to amiloride by forskolin-treated CFTR-/- swine showed 
wide dispersion, with some sites in a single lung displaying a large response to amiloride while 
other sites showed responses similar to that of wild-type tissues (Fig. 3-6 C). These data suggest 
that some sites in the distal airway of CFTR-/- swine have hyperactive ENaC while other of the 
sites seems to function normally. This is consistent with the observation that early CF airway 
disease development is not homogeneous throughout the lung, but rather, it manifests in discrete 
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sites of the small airway in CFTR-/- swine (Adam et al., 2013) as well as in CF infant patients 
(Wielpütz et al. 2016, Sly et al. 2009).  
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Figure 3-6: larger response to amiloride by distal airway of CFTR-/- swine. We use 
the response to the ENaC inhibitor, amiloride, as an assay for ENaC activity. A) Effect of 
forskolin on the response to amilorde by wild-type and CFTR-/- preparations. Insert display a 
sham experiment where the tissue was removed. B) Response to amiloride of wild-type swine 
that were never exposed to forskolin. C) Response to amiloride by thapsigargin-treated CFTR-/- 
and forskolin-treated CFTR-/- preparations. D) Thapsigargin triggers an increase in Na+ flux into 
the ASL in wild-type preparations and CFTR-/- swine preparations. Asterisk denotes statistical 
significant difference. 
 
B 
C D 
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To test whether ENaC hyperactivity in CFTR-/- is dependent on stimulation with Ca2+, 
we tested the effect of amiloride on preparations treated with thapsigargin, a SERCA blocker that 
increases intracellular Ca2+ concentrations and stimulates ion flux in airway epithelia (Terran et 
al., 2002). Stimulating preparations with thapsigargin triggered a significantly larger increase in 
Na+ flux into the ASL in wild-type preparations than in CFTR-/- swine preparations (Fig. 3-6 D, 
p < 0.05 repeated measures ANOVA, CFTR-/- n = 10 sites from 7 pigs, wild-type n = 7 sites 
from 4 pigs) but amiloride produced the same response in wild-type and in CFTR-/- airways 
(Fig. 8 D).  The response to amiloride by thapsigargin-treated CFTR-/- was significantly smaller 
than that of forskolin-treated CFTR-/- preparations (Fig. 3-6 C, p < 0.05 Students’ t test with 
Welch’s correction, forskolin+amiloride n = 12 sites from 8 pigs, thapsigargin+amiloride n = 10 
sites from 7 pigs). These data suggest that ENaC hyperactivity in CFTR-/- airway is indeed 
dependent on cAMP stimulation.  
 
4. Discussion  
Regulation of ASL production in normal airways is a complex process, involving 
submucosal glands and airway surface epithelial cells. In upper airways, submucosal glands 
contribute up 90% (Reid, 1960) of secretion of ASL, while in small airways ASL homeostasis is 
carried out by airway surface epithelial cells (Butcher, 2002). Since CF airway disease starts in 
the distal airways, there has been great interest in studying the airway surface epithelia 
physiology of the distal airways (Wine 2004; Tang et al. 2016). Studying the physiology of the 
distal airway is difficult, due the lack of experimental techniques with sufficiently spatial 
resolution to measure ion transport in native tissues. Thus, most studies have relied on cell 
cultures of distal airway epithelia to study ion transport, which has produced very important data 
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(Zabner et al., 1998; Knowles et al., 2002; Li et al., 2016). However, the use of tissue cultures 
has limitations, including the fact that cultured cells do not necessarily have the same phenotype 
as native epithelia (Shamsuddin & Quinton, 2012). In addition, culture cells lack other 
components of the native tissue, such as neurons, and connective tissue, that may contribute to 
normal function. This is an important impediment to our understanding of the pathobiology of 
CF airway disease.  
Thus, little is known about the ion transport in distal airway epithelia in native tissue. We 
decided to test sodium ion transport properties in CF and wild-type porcine small airways. Using 
SIET we investigate the Na+ fluxes with an unprecedented spatial and time resolution. Previous 
studies using radio labeled ions or Ussing chambers could only produce data on the ion transport 
properties of the entire tissue (i.e. folds and pleats). We present the first ever direct measurement 
of ion transport by the folds of the airway.  
The baseline activity of the small airway epithelium revealed both secretion and 
reabsorption of Na+. Moreover, stimulation with forskolin produced both secretion and later 
reabsorption of Na+ at a single site in the epithelium. Thus, our study revealed that the epithelium 
at the folds of small airway epithelia has the ability of bidirectional ion transport and rejects 
Quinton et al’s (2012) hypothesis that folds are only capable of absorptive functions. Our data 
also indicates that the epithelia at the folds respond to both ENaC and CFTR pharmacological 
blockers, suggesting that both CFTR and ENaC are expressed in the same cells. This suggests 
that CFTR-ENaC interaction is, indeed, possible.  
The response to amiloride by CFTR-/- pigs suggests that ENaC becomes hyperactive 
upon stimulation with cAMP. Thus, reconciling the enormous body of evidence of ENaC 
hyperactivity in CF (Hobbs et al., 2013; Althaus, 2013) with recent reports indicating normal 
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ENaC activity in CF tissues (Chen et al 2010, Hoegger 2014, Sun et al., 2010, Fisher et al., 2013, 
Tuggle at al., 2014, Itani et al., 2011). Our data also suggest that the contribution of ENaC to 
early disease should be tested at the sites of disease in early CF (Wielpütz, et al., 2014) and not 
in healthy upper airways because not all airways display the same phenotype.  
 
4.1 Baseline Na+ fluxes. 
Baseline sodium transport (i.e. without any stimulation) by the folds of the tissue was 
both positive and negative Na+ fluxes in different samples of distal airway tissues. The level of 
the secretion and reabsorption varied from sample to sample within the range of -100 to 100 
pmol cm-2 s-1 for CF tissues and 2 to 3-fold larger for wild-type tissues. That fact that we 
observed opposite direction of ion fluxes over the same group of cells on the folds, strongly 
suggests that these cells are capable of bidirectional sodium transport. In addition, our data also 
shows that CF tissue displayed significantly diminished reabsorption and secretion of ions 
compared with wild-type, consistent with previous reports that CF tissues have lower rate of 
fluid transport in either direction (Birket et al., 2014).  
 
4.2 Forskolin and thapsigargin stimulated secretion. 
Forskolin stimulates the production of c-AMP that phosphorylates the regulatory domains 
of CFTR and opens the channel. In CF, the function of CFTR is lost; thus, we would expect CF 
airways to be unresponsive to treatment with forskolin, and, thus not trigger secretion of ASL. 
Surprisingly, we recorded forskolin dependant increase of Na+ fluxes in CF, which in to cases 
were close to the mean of forskolin response in wild-type. The fact that forskolin could induce 
outward Na+ transport in CF airways might be the result of cAMP mediated activation of 
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basolateral K+ channels (Lohrmann et al., 1995; MacVinish, 1998), thus hyperpolarizing the 
membrane potential of the apical membrane, thus driving Na+ in to the lumen. Alternatively, 
cAMP may result in increased intracellular Ca2+ level and activation of Ca2+-activated Cl- 
channels (CACC) and increase ion secretion. However, the average of CF forskolin induced 
secretion was significantly lower than in WT.  
We tried to activate the CACC-dependent Cl- pathway by stimulating intracellular Ca2+ 
increase with thapsigargin, a SERCA blocker, to increase intracellular calcium. The data showed 
that stimulation with thapsigargin failed to invoke any significant changes in sodium transport in 
CF epithelia. However, WT samples stimulated with thapsigargin consistently showed elevation 
in Na+ fluxes.  
4.3 Amiloride inhibition of ENaC 
According to the previous studies (Zhou et al., 2011, Gaillard et al., 2010) CF epithelium 
might express hyperactive epithelial sodium channels (ENaC). We, therefore, tested the response 
of CFTR -/- to the ENaC inhibitor, amiloride, as an assay for Na+ transport since inhibiting 
ENaC in an epithelium that is capable of bidirectional NaCl transport would reveal the secretion 
component (Phillips et al., 1999). Moreover, the size of the amiloride response would directly 
depend on the ENaC activity before amiloride treatment. This proxy measurement (i.e. response 
to amiloride) has been used before to study ENaC function in the upper airway of CFTR-/- 
animal models (Chen et al., 2010, Sun et al., 2010, Fisher et al., 2013, Tuggle at al., 2014) and in 
CF human epithelial cell culture (Boucher et al., 1986, Itani et al., 2011). Pre-incubating wild-
type preparations with forskolin and then treating them with amiloride produced an increase in 
Na+ secretion into the PCL, which is consistent with previous reports showing that blocking 
ENaC increases secretion of fluid into the PCL (Blouquit et al. 2006). The response to amiloride 
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is as expected from an epithelium that is capable of bidirectional transport and the net fluid 
transport results from a balance between secretion, which is mediated by Cl- channels, and 
reabsorption, which is mediated by ENaC (Phillips et al., 1999). 
We observed that some localized regions showed amiloride induced higher than normal 
secretion in CFTR-/- tissue. Based on this result, we conclude that some regions of CF small 
airways might contain hyperactive ENaC, while others may not. This result is consisted with 
previous research suggesting increased reabsorption of Na+ in CF (Boucher et al. 1986).  
Boucher and colleagues also reported that in CF respiratory epithelia, hyperabsorption is not 
homogenously observed, but rather some localized spots in airway epithelia might express 
hyperactive ENaC.  
 
5. Conclusion  
Adequate hydration of the PCL is essential for efficient mucociliary clearance, the very 
basis of the lung’s innate defence system. A large body of evidence suggest that PCL volume is 
regulated to an optimal level by airway surface epithelial cells that are capable of bidirectional 
fluid transport (Phillips et al., 1999, Chamber et al., 2007), i.e. CFTR-mediated PCL secretion 
and ENaC-mediated PCL reabsorption. In normal airways CFTR inhibits ENaC, thus 
downregulating PCL reabsorption. In CF this process fails and PCL becomes dehydrated. This 
model has been recently challenged by reports that CFTR-/- do not display ENaC hyperactivity, 
and that the airway epithelial cells are not capable of bidirectional transport. 
Our data seems to show that airway surface epithelia are capable of bidirectional 
transport. In addition, it shows that CFTR-/- airway display higher than normal amiloride 
response in some sites ENaC after forskolin stimulation, suggesting hyperactive ENaC. 
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Based on our data and published reports the pathobiology of CF airway disease seems to 
by multi causal. There are ASL volume and properties dysfunction in CF, which favors the 
persistence of pathogens. In the distal airway, signals that would normally stimulate ASL 
secretion (such as cAMP) instead trigger hyperactive ENaC. One such signal may be the 
presence of pathogens. Hyperactive ENaC would cause mucociliary clearance collapse, failure of 
the innate immune system, and infection. Repeated cycles of infection and inflammation would 
trigger tissue remodeling that may eventually lead to respiratory failure. 
  
 
6. Appendix I: Tissue viability  
Concerns about tissue viability were addressed. We investigated the baseline sodium 
fluxes obtained during at different times after euthanasia. There was no correlation between the 
fluxes and the time after euthanasia up to 18 h. Since we performed our experiments within 12h 
after euthanasia, the tissue was viable and healthy. 
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Figure 6-1: Correlation of baseline sodium flux and time after euthanasia in WT swine. 
Data points are averages of baseline Na+ fluxes recorded within 10 min in different samples at 
different times after euthanasia (N=54 p=0.3104, R squared=0.01978).  
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7. Appendix II: Complete data on the effects of thapsigargin  
Ion and fluid transport by the airway surface epithelia can also be modulated by the 
intracellular second messenger, Ca2+ (Liedrke et al., 1989). Increases in intracellular Ca2+ trigger 
increases in Na+ and Cl- transport into the ASL through Ca2+ activated Cl- channels (CaCC) 
(Schreiber et al., 2005; Ruppersburg,& Hartzell. 2014) that can be stimulated with the SERCA 
blocker, thapsigargin (Ishii et al 1994; Lytton et al. 1991). We tested the role of Ca2+-dependent 
pathways on ion flux by stimulating our preparation with thapsigargin (1 µM, Terran et al., 
2002). Wild-type swine airway preparations responded to thapsigargin with a transient increase 
in Na+ flux into the ASL that peaked at 5 ± 2 min after treatment at 508 ± 102 pmol cm-2 s-1, 
which was significantly higher than the baseline secretion, then the tissues reversed to Na+ 
reabsorption from the ASL (Fig. 7-1 A). Preparations incubated with the CFTR inhibitor, 
CFTRinh172 (100 µM), responded no differently to thapsigargin than untreated preparations, 
suggesting a minimal contribution of CFTR to thapsigargin-stimulated Na+ flux (Fig. 7-1 C and 
D). However, CFTR-/- swine epithelia had a significantly smaller response to thapsigargin than 
that displayed by wild-type tissues and tissues incubated with the CFTR inhibitor (Fig. 7-1  B). 
This is an unexpected result since there is evidence that CFTR and CaCC functionally interact in 
such a way that CFTR reduces CaCC currents (Wei et al., 1999) and accordingly, CaCC is up 
regulated in CFTR-/- mouse tracheal epithelial cell cultures (Tarran et al. 2001). We therefore 
expected that thapsigargin response in CFTR-/- swine preparations would be larger than that in 
wild-type animals. Our results to the contrary would suggest that CaCC may be downregulated 
in CFTR-\- swine. CF airways may downregulate CaCC in response to increased levels of TGF-
beta in CF airways (Salvatore 2002). This may explain why human CF airway cells have a 
smaller response to the CaCC blocker, DIDS, compared to normal cells (Itani 2011) and also the 
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reduced response to cholinergic stimulation by submucosal glands in CFTR-/- swine airways 
(Wine, & Joo, (2004). The reduced CaCC function in CF airways may contribute to reduced 
ASL secretion in CF airways. 
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Figure 7-1: Effects of thapsigargin in CF and WT tissue. A. Thapsigargin stimulation of Na+ 
fluxes in wild-type airway epithelia. B. Effect of thapsigargin on CFTR-/- epithelia. C. Effect of 
thapsigargin CFTRinh172-treated wilt-type epithelia. D. Statistical analysis of thapsigargin 
responses in CF and wild-type epithelia showing significantly smaller response by CF epithelia 
(n =13,9,9; p<0.0004; non-parametric Kruskal-Wallis test) 
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8. Appendix III: There is no difference in ion transport between 1week-old and 2-3 
week-old animals 
 Since some data was obtained from 2-3 weeks-old swine. Our concern was if this data is 
consistent and comparable to results recorded from 2-7 day-old CFTR-/- samples. Thus, we 
compared the two age groups using the same drugs utilized in CFTR-/- experiments.  Our data 
revealed that 1 week-old and 2-3 weeks-old animals have the same response to forskolin, 
thapsigargin, and amiloride (Fig. 8-1). Thus there is no effect of age of the animals on our 
results.    
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Figure 8-1: Comparisons of drugs responses in tissue from 1 week-old (1wk) and 2-3 
weeks-old (2-3 wks) pigs.  A. Forskolin induced stimulation of Na+ secretion in 1wk and 2-3 
wks old WT pigs (n=10;11, p=0.9159, Mann Whitney test). B. Na+ fluxes analysis in two groups 
WT tissue 1 and 2-3 wks old pigs (n=8; 13, p=	  0.9135, Mann Whitney test). C. Amiloride-
conditioned Na+ secretion in porcine distal airways from two different age groups (n=11: 9, p=	  
0.1715). 
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9. Appendix IV: Mouse small airway   
While developing the pig model, I have simultaneously attempted to test the same 
hypothesis using mice small airways. Using mice as a model has several advantages. Firstly, it is 
more convenient to obtain mice and euthanize them immediately before using. Another 
advantage is the availability of many genetically modified mice to test different aspects of ASL 
secretion including CFTR- or ENaC- knockout mice. 
Although the mouse model seems to have lot of beneficial aspects, it turns out that it is 
difficult to perform these experiments in mice. The problem is that the mice’s small airways (1-
2mm in diameter) don’t have the same clear and distinct anatomical architecture of the epithelial 
layer as the swine model does. Thus, it is not possible to determine the pleats from the folds. 
Despite this disadvantage I continued using mice airways in order try to identify differences in 
ion flux properties (Fig. 9-1). Producing a frequency distribution, I did not find two populations 
of data as one would expect if there were a group of cells secreting and another absorbing Na+. 
In contrast the data distributed around 0 flux. Addition amiloride or NaN3, to inhibit active 
transport, resulted in a distribution tighter around 0.  
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Figure 9-1: Frequency distributions of Na+ flux in mice. A. Baseline distribution obtained in 
mourine distal airway epithelia (n=41). Data showed vague displacement of recordings with 90% 
of the data points were laid between -2000 and 2000 pmol cm-2 s-1. B. Amiloride effects on 
distribution of the Na+ fluxes in mouse small airways (n=41). C. Na azide modulations of the 
Baseline secretions of sodium, narrowed data points displacement within -800 to 600 pmol cm-2 
s-1 range  (n=21).  	  
A	   B	  
C	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